Max Healthcare Institute Ltd

Mid Cap

Healthcare Sector

reflects a positive outlook for the share price

reflects a neutral outlook for the share price

reflects a negative outlook for the share price

The analysts information is for reference only and does not\n  represents an investment recommendation.

Analyst recommendation reflect the views of analysts who follow and write research reports.

Company Information is an introduction to the company’s business that details what it sell, how it was founded, what their mission is, how they manufacture or source their products, and why they serve customers.

Max Healthcare announced plans to increase its capacity by over 8,900 beds, with approximately 4,600 beds to be added in the next 3-4 years.

Max Healthcare Expands Capacity Significantly - 20 Feb, 2026

Max Healthcare Institute demonstrates a bullish reversal with technical indicators suggesting a buy around ₹1,050-1,040, targeting ₹1,120-1,140. Anand Rathi maintains a buy rating with a target price of ₹1,300.

Max Healthcare Shows Bullish Trends and Buy Recommendation - 12 Feb, 2026

Max Healthcare reported a modest 2% YoY growth in EBITDA for 3QFY26, facing margin challenges due to various factors. Motilal Oswal maintains a target price of Rs 1,270 based on a sum-of-the-parts valuation.

Max Healthcare Faces Margin Challenges Despite Target Price - 11 Feb, 2026

Citi has reaffirmed its 'Buy' rating on Max Healthcare Institute Ltd, setting a target price of Rs 1,500, indicating confidence in the company's growth potential.

Citi Maintains Buy Rating on Max Healthcare - 09 Feb, 2026

Max Healthcare's management announced that the company has established agreements with insurance companies for annual price revisions, ensuring financial stability and adaptability in pricing.

Max Healthcare Secures Annual Price Revision Agreements - 06 Feb, 2026

Max Healthcare's Q3 FY26 results show a 26% rise in net profit and 10% revenue growth, despite margin compression due to regulatory actions and expansion costs. The company is expanding with a new hospital in Pune and additional beds, while international patient revenue also increased.

Max Healthcare Reports Strong Q3 Growth Amid Challenges - 05 Feb, 2026

Max Healthcare Institute shares gained significantly on February 1, 2026, following the Union Budget's proposal for five regional medical hubs, enhancing India's medical tourism potential.

Max Healthcare Shares Surge Post Union Budget Announcement - 01 Feb, 2026

Price to Earnings Ratio or Price to Earnings Multiple is the ratio of the share price of a stock to its earnings per share (EPS). It provides an indication of whether a stock at its current market price is expensive or cheap.

The price/earnings-to-growth ratio, or the PEG ratio, is a metric that helps investors value a stock by taking into account a company's market price, its earnings, and its future growth prospects.

Enterprise value (EV) is the total value of a company, defined in terms of its financing. It includes both the current share price (market capitalization) and the cost to pay off debt (net debt, or debt minus cash).

Alpha measures the amount that the investment has returned in comparison to the market index or other broad benchmark that it is compared against.

Beta measures a stock's volatility, the degree to which its price fluctuates in relation to the overall stock market. In other words, it gives a sense of the stock's risk compared to that of the greater market.

Dividend yield measures the quantum of earnings by way of total dividends that investors make by investing in that company.

The debt-to-total-assets ratio shows how much of a business is owned by creditors (people it has borrowed money from) compared with how much of the company's assets are owned by shareholders.

Operating cash flow (OCF) is a measure of the amount of cash generated by a company's normal business operations. Operating cash flow indicates whether a company can generate sufficient positive cash flow to maintain and grow its operations.

This widget shows the information about the stock's peers in consideration along with the different data for those peers so that the user can compare the stock with the other similar stock and invest accordingly.

Promoter holding is the amount of share of the company that is owned by the promoters. The promoters are the company's founders, who hold a majority stake in the company's capital.

A foreign institutional investor (FII) is an investor or investment fund investing in a country outside of the one in which it is registered or headquartered.

A mutual fund is a pool of money managed by a professional Fund Manager. It is a trust that collects money from a number of investors who share a common investment objective and invests the same in equities, bonds, money market instruments, and other securities.

Retail investors execute their trades through traditional or online brokerage firms or other types of investment accounts. Retail investors purchase securities for their own personal accounts and often trade in dramatically smaller amounts as compared to institutional investors.

This widget shows the bifurcation of stocks based on the percentage of stake with the different types of shareholders.

This widget will help value the stock based on the Price to Earning ratio of the stock and compare the valuation with the industry value and other similar stocks. It even shows the timeline of the valuation of the stock and its highest and lowest valuation over time.
A Time Series data is provided which compares the historical stock PE with Industry PE over the period of 5 years.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

Retail Investor have increased holdings from 4.43% to 4.52% in Dec 2025 quarter

This section gives you an insight into how the Retail Investors Holding has changed for the stock over last few quarters.

Retail Holding Up

In the last 1 year, Fortis Healthcare Ltd has given 40.8% return, outperforming this stock by 34.7%

This section gives you an insight into how the peers have performed as compared to this company in the last 1 year.

Against Peers

In the last 3 years, Fortis Healthcare Ltd has given 229.4% return, outperforming this stock by 104.0%

This section gives you an insight into how the peers have performed as compared to this company in the last 3 years.

Revenue is down for the last 2 quarters, 2.16K Cr → 2.11K Cr (in ₹), with an average decrease of 2.6% per quarter

This section gives you an insight into how the revenue of the company has moved for the last few quarters.

Revenue Fall

In the last 1 month, MAXHEALTH stock has moved down by -1.1%

This section gives you an insight into the price movement of the stock for the last few quarters.

Price Dip

Promoters have decreased holdings from 23.74% to 23.72% in Dec 2025 quarter

This section gives you an insight into how the Promoter Holding has changed for the stock over the last few quarters.

Promoter Holding Down

Mutual Funds have decreased holdings from 14.25% to 14.04% in Dec 2025 quarter

This section gives you an insight into how the Mutual Funds Holding has changed for the stock over last few quarters.

MF Holding Down

Foreign Institutions have decreased holdings from 51.80% to 50.55% in Dec 2025 quarter

This section gives you an insight into how the FII Holding has changed for the stock over last few quarters.

FII Holding Down

Netprofit is down for the last 2 quarters, 491.3 Cr → 300.92 Cr (in ₹), with an average decrease of 38.8% per quarter

This section gives you an insight into how the profit for the company has been for the last few quarters.

Profit Down

NIFTY 50

NIFTY 100

S&P BSE 100 LargeCap TMC

Nifty Alpha 50

Nifty Healthcare

S&P BSE SENSEX 50

S&P BSE 250 LargeMidCap

BSE 100

Nifty100 Eq Weig

S&P BSE Momentum

Nifty Infra

BSE Healthcare

S&P BSE 100 ESG

Nifty 500

Nifty Services Sector

Nifty LargeMidcap 250

BSE 200

Nifty India Consumption

Nifty 200

BSE 500

SBI Equity Hybrid Fund Direct Growth

Nippon India Growth Mid Cap Fund - Direct Plan - Growth Mid Cap

Invesco India Large&MidCap Fund Direct Plan Growth

HDFC Flexi Cap Fund -Direct Plan - Growth Option

Kotak Midcap Fund Direct Growth

Max Healthcare Institute Ltd’s net profit jumped 26.01% since last year same period to ₹300.92Cr in the Q3 2025-2026. On a quarterly growth basis, Max Healthcare Institute Ltd has generated -38.75% fall in its net profits since last 3-months.

Max Healthcare Institute Ltd Earnings Results

In the quarter ending March 2025, Max Healthcare Institute Ltd has declared dividend of ₹1.50 per share on 20 May 2025 - translating a dividend yield of 0.29%.

Name	Value	Action
MACD level (12,26)	-0.87	Bearish
CCI (20)	38.83	Neutral
RSI (14)	30.47	Neutral
Momentum (10)	-4	Bearish
ADI (14)	34.42	Bearish
Ultimate Oscillator (7,14,28)	33.19	Neutral

Name	Value	Action
SMA (20)	1033.01	Bearish
EMA (20)	1032.37	Bearish
VWMA (20)	1032.27	Bearish
SMA (50)	1033.32	Bearish
EMA (50)	1033.06	Bearish
SMA (200)	1032.49	Bearish
EMA (200)	1033.25	Bearish
KAMA (200)	1033.95	Bearish
DEMA (200)	1032.37	Bearish

Max Healthcare Institute Ltd (MAXHEALTH)

Summary

Overall

Oscillators

Moving Averages